2016年4月21日下午，复旦大学药学院院长、国家新药筛选中心主任兼国家化合物样品库主任王明伟研究员在北京会晤了位于美国加州硅谷的生物技术公司Synthego的首席执行官Paul Dabrowski和总裁Michael Dabrowski兄弟俩，与他们讨论了高通量RNA合成技术的最新进展并邀请其方便时访问张江“药谷”，共商合作大计。
Dr. Ming-Wei Wang meets Dabrowski brothers of Synthego (U.S.A.) in Beijing
In the afternoon of April 21, 2016, Dr. Ming-Wei Wang, Dean of School of Pharmacy, Fudan University and Director of the National Center for Drug Screening/Chinese National Compound Library, met with Mr. Paul Dabrowski (Chief Executive Officer) and Mr. Michael Dabrowski (President) of Synthego Corporation, based in Silicon Valley, California (U.S.A.), at Beijing. They discussed the latest advancement in high-throughput RNA synthesis. Dr. Wang invited the Dabrowski brothers to visit Zhangjiang “Pharma Valley” when convenient to plan collaboration.
